These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 779206)

  • 1. Recent studies on the immunobiology and virology of human urothelial tumors.
    Fraley EE; Lange PH; Hakala TR
    Urol Clin North Am; 1976 Feb; 3(1):31-51. PubMed ID: 779206
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation of an RNA virus from transitional cell tumors of the human urinary bladder.
    Elliott AY; Fraley EE; Castro AE; Cleveland P; Hakala T; Stein N
    Surgery; 1973 Jul; 74(1):46-50. PubMed ID: 4123732
    [No Abstract]   [Full Text] [Related]  

  • 3. RNA virus associated with human transitional cell cancers of the urinary tract.
    Fraley EE; Elliott AY; Cleveland P; Stein N
    Minn Med; 1974 Nov; 57(11):871-5. PubMed ID: 4425349
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide.
    Nishiyama T; Tachibana M; Horiguchi Y; Nakamura K; Ikeda Y; Takesako K; Murai M
    Clin Cancer Res; 2001 Jan; 7(1):23-31. PubMed ID: 11205913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oncogenic viruses--a review].
    Schäfer W
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):3-26. PubMed ID: 4145610
    [No Abstract]   [Full Text] [Related]  

  • 6. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral and immunologic studies of human neoplasms.
    Malmgren RA; Morton DL
    Pathobiol Annu; 1971; 1():63-81. PubMed ID: 4359566
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cell transformation by oncogenic DNA viruses].
    Westphal H
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):27-38. PubMed ID: 4122875
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoclonal antibodies to cell surface antigens shared by chemically induced mouse bladder carcinomas.
    Hellström I; Hellström KE; Rollins N; Lee VK; Hudkins KL; Nepom GT
    Cancer Res; 1985 May; 45(5):2210-8. PubMed ID: 3986770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder.
    Furihata M; Inoue K; Ohtsuki Y; Hashimoto H; Terao N; Fujita Y
    Cancer Res; 1993 Oct; 53(20):4823-7. PubMed ID: 8402668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human transitional cell carcinoma in the NMRI-nu/nu mouse bladder: a new animal model for the in vivo use of monoclonal antibodies and cytotoxic agents.
    Huland E; Arndt R; Huland H
    Cancer Res; 1986 May; 46(5):2488-9. PubMed ID: 3697989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic markers in transitional carcinoma of the bladder].
    Blasco E; Gutiérrez-Hoyos A; Garrido C; Arozena F
    Arch Esp Urol; 1991; 44(1):47-52. PubMed ID: 2064423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chicken RNA tumor viruses: a model for virus-induced carcinogenesis].
    Bauer H; Bolognesi DP; Gelderblom H; Graf T; Kurth R; Mölling K
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):66-78. PubMed ID: 4145639
    [No Abstract]   [Full Text] [Related]  

  • 14. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
    Ben-Aïssa H; Paulie S; Gustafsson B; Håkansson L; Lagerkvist M; Gustafson H; Ahlstrand C; Perlmann P
    Anticancer Res; 1988; 8(3):443-9. PubMed ID: 3389746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro production of human antibodies against bladder cancer: characterization and diagnostic implications.
    Pizza G; De Vinci C
    J Exp Pathol; 1987; 3(4):335-46. PubMed ID: 2457663
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the mechanical integration of transitional epithelial cells and in the immune status of patients with bladder tumors].
    Bocharova OA; Serebriakova RV; Golubeva VA; Figurin KM; Bukharkin BV; Bodrova NB; Matveev BP; Baryshnikov AIu
    Urol Nefrol (Mosk); 1994; (3):27-30. PubMed ID: 8079407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytokine therapy of superficial bladder carcinoma. Mechanisms of action and results of therapy].
    Otto T; Kälble T
    Urologe A; 1994 Nov; 33(6):540-6. PubMed ID: 7817454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary evaluation of tumor-associated antigens in urothelial bladder tumors.
    Piana P; Casetta G; Cavallini A; Piantino P; Tizzani A
    Prog Clin Biol Res; 1991; 370():179-84. PubMed ID: 1924448
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoclonal antibodies raised against cell membrane components of human bladder tumor tissue recognizing subpopulations in normal urothelium.
    Summerhayes IC; McIlhinney RA; Ponder BA; Shearer RJ; Pocock RD
    J Natl Cancer Inst; 1985 Dec; 75(6):1025-38. PubMed ID: 2415743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology of the bladder.
    Graham SD
    Urol Clin North Am; 1992 Aug; 19(3):541-8. PubMed ID: 1636238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.